Efficacy, Safety, and Feasibility of Verapamil in the Management of Atrial Fibrillation in Emergency Services with Limited Resources: A Systematic Review

Introduction: Atrial fibrillation represents one of the most frequent arrhythmias in emergency services, particularly in settings with limited resources where clear protocols and accessible drugs are required. Verapamil shows significant potential for controlling ventricular rate, although it faces various implementation challenges. This study systematically evaluates its efficacy, safety, and feasibility in emergency contexts with limited resources.  Methods: A systematic review was conducted following PRISMA guidelines. The search was performed in MEDLINE/PubMed, Embase, Cochrane Library, LILACS, and Google Scholar (January 2000-June 2024), including observational studies, clinical trials, and economic evaluations. Specific MeSH terms related to verapamil and atrial fibrillation in emergencies were used. Two independent reviewers assessed methodological quality using GRADE and Newcastle-Ottawa scales.  Results: Of 487 articles identified, 42 met inclusion criteria. Verapamil demonstrated efficacy in ventricular rate control (mean reduction of 25-35 bpm in 30 minutes) with a favorable safety profile (NNH for significant hypotension: 38). Structured protocols reduced hospital admissions (18%, p<0.01) and need for cardioversions (22%, p<0.005) without requiring additional personnel. Economic analyses showed cost reduction ($420-680 per patient) by reducing admissions and hospital stays. "Wait and see" strategies proved viable in selected patients (CHA2DS2-VASc <2, without ventricular dysfunction).  Discussion: The findings demonstrate that verapamil, when implemented within structured protocols, represents an effective alternative for ventricular rate control in atrial fibrillation in emergency services. Its favorable safety profile, with a number needed to harm (NNH) of 38 for significant hypotension, suggests a manageable risk in controlled settings. The significant reductions in hospital admissions and need for cardioversions have important implications for healthcare systems with limited resources, where resource optimization is crucial. Additionally, the documented economic benefits reinforce its value as a cost-efficient intervention.  Conclusions: Verapamil constitutes an effective, safe, and cost-efficient option for the management of atrial fibrillation in emergency settings with limited resources when implemented within structured protocols. It is recommended to develop standardized guidelines, improve transition to outpatient care, and conduct larger comparative studies to optimize its use in various clinical contexts.

• Publication year

  2025

• Venue

  International Journal of Innovative Science and Research Technology

• Publication date

  2025-07-31

• Fields of study

  Not labeled

• Identifiers
  DOI 10.38124/ijisrt/25jul1494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial.

  2020cited by this paper
• The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.

  2020cited by this paper
• A Multicenter Randomized Trial to Evaluate a Chemical-first or Electrical-first Cardioversion Strategy for Patients With Uncomplicated Acute Atrial Fibrillation.

  2019cited by this paper
• RoB 2: a revised tool for assessing risk of bias in randomised trials

  2019cited by this paper
• Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2019cited by this paper
• Creation and Implementation of an Outpatient Pathway for Atrial Fibrillation in the Emergency Department Setting: Results of an Expert Panel

  2018cited by this paper
• Implementation of an emergency department atrial fibrillation and flutter pathway improves rates of appropriate anticoagulation, reduces length of stay and thirty-day revisit rates for congestive heart failure.

  2018cited by this paper
• Emergency Department Visits for Atrial Fibrillation in the United States: Trends in Admission Rates and Economic Burden From 2007 to 2014

  2018cited by this paper
• Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation: Coll-Vinent B, Martín A, Sánchez J, et al. Stroke 2017;48:1344-1352

  2017cited by this paper
• AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

  2017cited by this paper
• Guidelines on the management of atrial fibrillation in the emergency department: a critical appraisal

  2017cited by this paper
• [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS].

  2016cited by this paper
• Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.

  2015cited by this paper
• &bgr;-Blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review

  2015cited by this paper
• Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study

  2014cited by this paper
• Burden of disease from atrial fibrillation in adults from seven countries in Latin America

  2014cited by this paper
• Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

  2013cited by this paper
• Managing emergency department patients with recent-onset atrial fibrillation.

  2012cited by this paper
• An international view of how recent-onset atrial fibrillation is treated in the emergency department.

  2012cited by this paper
• Access to emergency and surgical care in sub-Saharan Africa: the infrastructure gap.

  2012cited by this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cited by this paper
• Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation

  2005cited by this paper
• Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias

  2001cited by this paper
• Prospective, randomized trial of template-assisted versus undirected written recording of physician records in the emergency department.

  1999cited by this paper
• Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group.

  1989cited by this paper

• No citing papers are available for this paper.